Comradis is an agency dedicated to supporting the development of, and access to, effective treatments for rare diseases and uncommon cancers. Our team provides communications and commercialization expertise to pharmaceutical companies, rare disease specialists and patient advocacy organizations looking to improve standards of care for those affected by rare diseases and uncommon cancers. Our goal is to ensure that novel therapies reach those who need them as quickly and cost-efficiently as possible. Comradis is part of AMICULUM®, an independent family of healthcare communications, consulting and learning businesses with team members based in Europe, Asia-Pacific, MENA, and the USA. Please direct any enquiries about Comradis to ellie.thomas@comradis.biz
| Website | http://www.comradis.biz |
| Revenue | $6 million |
| Employees | 23 (1 on RocketReach) |
| Founded | 2013 |
| Technologies |
JavaScript
,
HTML
,
Google Analytics
+5 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing, Manufacturing General, Manufacturing |
| Keywords | Rare Diseases, Rare Disease Advocacy, Orphan Drugs, Pharmaceutical Communications, Patient Advocacy, Pharmaceutical Consulting, Drug Development, Oncology, Precision Medicine, Clinical Trials, Commercialization Strategy, Biopharma, Drug Commercialization, Market Access, Medical Affairs, Health Communication, Regulatory Affairs, Healthcare Marketing |
| Competitors | Johnson & Johnson, Roche, AbbVie, Novartis, Merck & Co., Inc., Pfizer, Sanofi, GSK, AstraZeneca, Bristol Myers Squibb +38 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies |
Looking for a particular Comradis employee's phone or email?
The Comradis annual revenue was $6 million in 2026.
1 people are employed at Comradis.
The NAICS codes for Comradis are [32541, 325, 3254, 32].
The SIC codes for Comradis are [28, 283].